Baylor College Of Medicine
Clinical trials sponsored by Baylor College Of Medicine, explained in plain language.
-
Teen heart health: could carnitine be the key?
Disease control OngoingThis study looks at whether a protein supplement called carnitine can reduce hardening of the arteries in teenagers at high risk for heart disease. About 90 teens aged 11-21 with high triglycerides will take carnitine or a placebo. The goal is to see if carnitine can improve arte…
Phase: PHASE2 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated May 26, 2026 10:49 UTC
-
Engineered immune cells injected directly into brain tumors: a new hope?
Disease control OngoingThis early-phase study tests a new treatment for people with HER2-positive brain tumors that have come back or not responded to standard care. The treatment involves taking a patient's own immune cells (T cells), adding a special antibody (HER2-CAR) to help them recognize and att…
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated May 26, 2026 10:48 UTC
-
Gene-Edited immune cells take on tough lymphoma
Disease control OngoingThis early-phase study tests a new cell therapy for patients with relapsed EBV-positive lymphoma. The treatment uses the patient's own immune cells, modified to resist a tumor's defense mechanism (TGFb) and trained to attack cancer cells. The main goals are to find a safe dose an…
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated May 26, 2026 10:48 UTC
-
Donor immune cells trained to hunt cancer show promise in blood cancers
Disease control OngoingThis early-phase study tests a new therapy using donor immune cells trained to recognize four proteins found on AML and MDS cancer cells. The cells are given to patients at least 30 days after a stem cell transplant. The main goal is to find the safest dose and see if the cells c…
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated May 26, 2026 10:47 UTC
-
Engineered t cells take on sarcoma in early trial
Disease control OngoingThis study tests a new treatment for people with advanced sarcoma, a type of cancer. Researchers take the patient's own immune cells (T cells) and add a new gene to help them recognize and attack cancer cells that have a protein called HER2. Before the cells are given back, some …
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated May 26, 2026 10:46 UTC
-
Donor immune cells show promise against relapsed blood cancers
Disease control OngoingThis early-phase study tests a new treatment for people with certain blood cancers (lymphoma or leukemia) that have returned after a stem cell transplant. Researchers take immune cells (T cells) from the original stem cell donor, modify them to recognize and attack cancer cells c…
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated May 26, 2026 10:45 UTC
-
New combo therapy aims to shield gut in transplant patients
Disease control TerminatedThis study was designed to test whether adding a drug called 5-azacytidine (AZA) to standard steroid treatment is safe and feasible for people with gut graft-versus-host disease (GVHD) after a stem cell transplant. GVHD occurs when donor cells attack the patient's body, and gut i…
Phase: EARLY_PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated May 26, 2026 10:45 UTC
-
Engineered t cells take on Hard-to-Treat blood cancers
Disease control OngoingThis study tests a new treatment for people with certain blood cancers (lymphoma, multiple myeloma, or CLL) that have returned or not responded to standard therapy. Researchers take a patient's own immune cells (T cells) and modify them in the lab to better recognize and attack c…
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated May 26, 2026 10:42 UTC
-
Leukemia drug holiday: study tests if patients can pause treatment
Disease control OngoingThis study looks at whether people with chronic myeloid leukemia (CML) who have had a very low level of cancer for at least two years can safely stop taking their daily targeted therapy (TKI). Seventeen adults who have been on TKI for over three years will stop their medication a…
Phase: PHASE2 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated May 26, 2026 10:41 UTC
-
Engineered immune cells take aim at Hard-to-Treat leukemia
Disease control OngoingThis study tests a new treatment for adults with acute myeloid leukemia (AML) that has returned or not responded to standard therapy. The treatment uses the patient's own immune cells (T cells) that are modified in the lab to recognize and attack AML cells carrying a protein call…
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated May 26, 2026 10:35 UTC
-
Engineered immune cells take on Hard-to-Treat blood cancers
Disease control OngoingThis early-stage study tests a new cell therapy called ANCHOR cells for people with B-cell lymphoma or leukemia that has returned or not responded to standard treatments. The cells are made from a healthy donor's immune cells and are modified to better recognize and attack cancer…
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated May 26, 2026 10:35 UTC
-
Supercharged t cells take on childhood liver cancer
Disease control OngoingThis early-phase study tests a new treatment called GAP T cells for children and young adults with a type of liver cancer that has returned or not responded to standard therapy. The treatment involves taking a patient's own immune cells, adding a gene to help them recognize and a…
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated May 26, 2026 10:34 UTC
-
Donor immune cells show promise against Virus-Linked cancers
Disease control OngoingThis study tests whether specially trained immune cells from healthy donors can safely fight cancers and diseases caused by the Epstein-Barr virus (EBV). The cells are made quickly in the lab and stored in a bank, so they are ready for patients whose cancer has returned or not re…
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated May 26, 2026 10:31 UTC
-
Engineered t cells take on Hard-to-Treat cancers
Disease control OngoingThis early-phase study tests a new treatment called CATCH T cells for people with certain solid tumors (like liver cancer) that have come back or not responded to standard care. The treatment involves taking a patient's own immune cells, adding special genes to help them recogniz…
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated May 22, 2026 14:04 UTC
-
Supercharged immune cells take on nasopharyngeal cancer
Disease control OngoingThis early-stage study tests a new immune cell therapy for people with a type of throat cancer linked to the Epstein-Barr virus. Researchers take the patient's own T cells, train them to recognize the virus on cancer cells, and add a gene to make them resist a chemical that tumor…
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
New transplant technique aims to cut deadly immune reaction in half-matched donors
Disease control OngoingThis study tests a stem cell transplant method that filters out certain immune cells (TCRαβ+ and CD19+) from a half-matched family donor's blood. The goal is to lower the risk of graft-versus-host disease, a serious complication, and allow patients to avoid long-term immune-suppr…
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
Supercharged immune cells take on Hard-to-Treat lymphoma
Disease control OngoingThis early-phase study tests a new way to fight Hodgkin and non-Hodgkin lymphoma that has returned or not responded to standard treatment. Researchers take a patient's own immune cells (T cells), add a special receptor that targets the CD30 protein on lymphoma cells, and also tra…
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
Supercharged immune cells take on childhood cancers
Disease control OngoingThis early-stage trial tests a new treatment called AGAR T cells for children whose solid tumors (like liver cancer or rhabdomyosarcoma) have returned or not responded to standard care. The treatment involves taking a patient's own immune cells, adding genes to help them recogniz…
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
Engineered immune cells target Hard-to-Treat childhood cancers
Disease control OngoingThis early-phase study tests a new treatment for advanced osteosarcoma and neuroblastoma that has not responded to standard therapies. The approach uses a patient's own immune cells (T cells) that are genetically modified to recognize and attack cancer cells carrying a protein ca…
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
Can a simple step-by-step program help fight fatty liver? new study seeks answers.
Disease control OngoingThis study tests whether a weight loss program called "Paso a Paso" is practical for 50 Mexican and Central American adults with fatty liver disease and overweight. Researchers will check if participants attend enough sessions and if the program helps with weight loss, liver heal…
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
Video boost for HIV teens: study tests new way to stay on track
Disease control OngoingThis study tests a video-based program called VITAL Start for Adolescents to help teens living with HIV take their medicine regularly and keep the virus under control. About 1,800 teens and their caregivers in Malawi will either watch the videos plus get standard care, or just st…
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated May 20, 2026 11:55 UTC
-
Engineered t cells take aim at Hard-to-Treat blood cancers
Disease control OngoingThis early-phase study tests a new approach for people with B-cell lymphoma or leukemia that has returned or not responded to standard therapy. Researchers take a patient's own immune cells (T cells), modify them in the lab to recognize and attack cancer cells carrying the CD19 p…
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated May 19, 2026 11:59 UTC
-
Engineered immune cells target Hard-to-Treat childhood cancer
Disease control OngoingThis early-phase study tests a new gene therapy for children with neuroblastoma that has come back or not responded to treatment. The therapy uses the patient's own immune cells (T cells) that are modified in the lab to recognize and attack neuroblastoma cells. The study aims to …
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated May 18, 2026 12:01 UTC
-
New ultrasound otoscope could revolutionize ear infection diagnosis in kids
Diagnosis OngoingThis study is testing a new device that uses ultrasound to look inside the ear and help doctors diagnose middle ear infections more accurately. About 300 children scheduled for ear tube surgery will have their ears examined with the prototype device. The goal is to collect data t…
Sponsor: Baylor College of Medicine • Aim: Diagnosis
Last updated May 26, 2026 10:46 UTC
-
Family fitness: new program targets hispanic dads to fight childhood obesity
Prevention OngoingThis study tests a program called 'Healthy Dads, Healthy Kids' adapted for Hispanic families. It aims to help fathers lose weight and increase their children's physical activity to prevent obesity. About 187 fathers and their children (ages 5-11) from the Houston area are taking …
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Prevention
Last updated May 26, 2026 10:49 UTC
-
At-Home HPV test mailed to asian women could prevent cervical cancer
Prevention OngoingThis study looks at whether mailing self-sampling HPV test kits to Asian and Asian American women who are behind on screening can help them get tested for cervical cancer. About 111 women in Houston, Texas, who haven't had a Pap test in years will receive a kit to collect their o…
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Prevention
Last updated May 26, 2026 10:32 UTC
-
Ear acupuncture study aimed to cut opioid use after leg surgery – but never started
Symptom relief TerminatedThis study planned to test whether adding ear acupuncture during surgery to repair a broken lower leg could help patients use fewer opioid painkillers afterward. It was designed for adults aged 18–64 having ankle or foot fracture surgery. However, the study was withdrawn before e…
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Symptom relief
Last updated May 26, 2026 10:48 UTC
-
Invisalign offers hope for safer smiles in brittle bone disease
Symptom relief OngoingThis study tests whether Invisalign clear aligners can safely and effectively straighten teeth in people with Osteogenesis Imperfecta (OI), a condition that makes bones brittle and teeth fragile. Traditional braces can be risky for OI patients, so researchers are evaluating a les…
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Symptom relief
Last updated May 26, 2026 10:47 UTC
-
Acupuncture aims to slash opioid use after broken wrist repair
Symptom relief TerminatedThis study planned to test whether giving ear acupuncture during wrist surgery could lower the amount of opioid painkillers patients need afterward. It was designed for adults aged 18-64 having a specific type of wrist fracture repair. However, the study was withdrawn before any …
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Symptom relief
Last updated May 26, 2026 10:44 UTC
-
Can telehealth therapy help kids with anxiety and OCD?
Symptom relief OngoingThis study compares two family-based behavioral treatments delivered via telehealth for children aged 7-13 with anxiety or obsessive-compulsive disorder (OCD). The goal is to see if these lower-intensity therapies work as well as a relaxation and mentorship program. About 100 chi…
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Symptom relief
Last updated May 26, 2026 10:43 UTC
-
Which knife is better for colon surgery? new trial aims to find out
Symptom relief OngoingThis study compares a new bipolar knife to a standard monopolar knife for removing colon growths during a procedure called endoscopic submucosal dissection (ESD). About 80 adults with colon growths will be randomly assigned to one knife. The goal is to see which knife works faste…
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Symptom relief
Last updated May 26, 2026 10:32 UTC
-
Veterans with epilepsy may get relief from a migraine device
Symptom relief OngoingThis study tests whether a non-invasive headband device called Cefaly, originally approved for migraines, can help reduce seizures in veterans with drug-resistant epilepsy. 24 veterans will take part, with half using the device plus standard care and half receiving standard care …
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Symptom relief
Last updated May 26, 2026 10:31 UTC
-
New knife may cut pain in esophageal surgery trial
Symptom relief OngoingThis study compares two different knives used during a procedure called POEM, which helps people with swallowing disorders like achalasia. The goal is to see if a newer bipolar knife causes less pain after surgery and requires fewer tool changes than the standard monopolar knife.…
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Symptom relief
Last updated May 22, 2026 14:05 UTC
-
New study offers moms in NICU mental health support and basic needs help
Symptom relief OngoingThis study aims to help mothers of babies in the hospital cope with depression and anxiety while strengthening their bond with their baby. It also connects families to resources for food, housing, and other household needs. About 200 English- or Spanish-speaking caregivers of inf…
Sponsor: Baylor College of Medicine • Aim: Symptom relief
Last updated May 22, 2026 14:03 UTC
-
Parent videos show promise for teens with eating disorders
Symptom relief ENROLLING_BY_INVITATIONThis study tests whether a series of short educational videos for parents can help them better support their adolescent child with anorexia or atypical anorexia. About 50 parent-teen pairs will take part. Parents who watch the videos alongside standard treatment will be compared …
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Symptom relief
Last updated May 20, 2026 11:55 UTC
-
Can a simple blood test catch HPV cancers early in men?
Knowledge-focused OngoingThis study looks at whether testing men for HPV antibodies or HPV DNA in their blood can help find throat and anal cancers early. Researchers will follow 1,500 men who test positive for these markers to see how many develop cancer. The goal is to improve screening and catch these…
Sponsor: Baylor College of Medicine • Aim: Knowledge-focused
Last updated May 26, 2026 10:48 UTC
-
Can a few home visits help moms feel less stressed and more supported?
Knowledge-focused OngoingThis study looks at whether a brief home visitation program, delivered by non-nurse visitors, can help pregnant and postpartum women connect to community resources, feel more confident about their health, and reduce stress. About 450 women will be randomly assigned to either rece…
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Knowledge-focused
Last updated May 26, 2026 10:47 UTC
-
Gum study hopes to boost mom and baby health in malawi
Knowledge-focused OngoingThis study looks at whether chewing xylitol gum during pregnancy can change the bacteria in the mouth and vagina, reduce gum inflammation, and improve pregnancy outcomes. Researchers in Malawi will follow 80 pregnant women and their babies to check gum health, pregnancy complicat…
Phase: PHASE1, PHASE2 • Sponsor: Baylor College of Medicine • Aim: Knowledge-focused
Last updated May 26, 2026 10:46 UTC
-
Brain antioxidant trial hopes to unlock memory secrets
Knowledge-focused OngoingThis study looks at whether increasing glutathione, a natural antioxidant in the body, can improve thinking and memory in older adults with mild cognitive impairment. Sixty participants will take either glutathione-boosting supplements or a placebo for 12 weeks, then stop for ano…
Phase: EARLY_PHASE1 • Sponsor: Baylor College of Medicine • Aim: Knowledge-focused
Last updated May 26, 2026 10:44 UTC
-
Breast milk mouth care may help Rare-Belly babies eat sooner
Knowledge-focused OngoingThis study tests if giving small amounts of breast milk in the mouth (oral care) helps babies born with gastroschisis, a rare hole in the belly wall, tolerate feedings and avoid infections. Researchers will compare babies who get breast milk oral care to those who get sterile wat…
Sponsor: Baylor College of Medicine • Aim: Knowledge-focused
Last updated May 26, 2026 10:41 UTC
-
Pee power: urine test may replace needles for brittle bone diagnosis
Knowledge-focused OngoingThis study is testing whether a urine sample can be used to identify different genetic types of osteogenesis imperfecta (OI), a rare condition that makes bones break easily. Researchers will measure specific collagen breakdown products in the urine of 25 people with OI and compar…
Sponsor: Baylor College of Medicine • Aim: Knowledge-focused
Last updated May 26, 2026 10:40 UTC
-
Brittle bone study aims to solve breathing mystery
Knowledge-focused OngoingThis study looks at how osteogenesis imperfecta (brittle bone disease) affects the lungs and heart. Researchers will measure lung function and use CT scans in 18 adults to find out why breathing problems are common. The goal is to better understand the disease, not to test a new …
Sponsor: Baylor College of Medicine • Aim: Knowledge-focused
Last updated May 26, 2026 10:40 UTC
-
Scientists hunt for genetic clues behind rare molar pregnancies
Knowledge-focused OngoingThis study aims to find the genetic changes that cause recurrent hydatidiform moles, a rare type of pregnancy where tissue grows abnormally in the womb. Researchers will analyze DNA from up to 100 women with a personal or family history of these moles, as well as some relatives. …
Sponsor: Baylor College of Medicine • Aim: Knowledge-focused
Last updated May 26, 2026 10:35 UTC
-
Donor milk study tracks preemie growth after NICU
Knowledge-focused OngoingThis study follows about 51 premature babies (born before 37 weeks and weighing 2.75 pounds or less) who were fed donor human milk while in the NICU. Researchers want to see how these infants grow and develop after they go home. The goal is to learn whether an exclusive human mil…
Sponsor: Baylor College of Medicine • Aim: Knowledge-focused
Last updated May 26, 2026 10:34 UTC
-
Brittle bones, broken smiles: new study looks at teeth alignment in OI
Knowledge-focused OngoingThis study looks at dental and skull problems in people with moderate to severe osteogenesis imperfecta (OI), a rare condition that causes bones to break easily. Researchers will use scans to measure teeth misalignment and neck defects in 75 participants aged 10 and older. The go…
Sponsor: Baylor College of Medicine • Aim: Knowledge-focused
Last updated May 22, 2026 14:05 UTC
-
Brain implant learns to detect OCD symptoms in real time
Knowledge-focused OngoingThis study is for people with severe, hard-to-treat OCD. Researchers are testing an advanced brain stimulation system that can adapt to a person's needs. The goal is to find brain signals linked to OCD distress and improve how deep brain stimulation works. Only 2 people will take…
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Knowledge-focused
Last updated May 22, 2026 14:02 UTC
-
New study uses simple tests to detect hidden liver damage in rare genetic disease
Knowledge-focused OngoingThis study looks at how well noninvasive tests (like blood markers and special scans) can detect liver scarring in people with urea cycle disorders. About 62 participants aged 6 to 65 will undergo these tests at five medical centers. The goal is to find better ways to monitor liv…
Sponsor: Baylor College of Medicine • Aim: Knowledge-focused
Last updated May 22, 2026 14:02 UTC
-
Scientists hunt for genetic clues behind rare goltz syndrome
Knowledge-focused OngoingThis study aims to better understand the genetic causes of Goltz syndrome, a rare condition that affects skin, bones, eyes, and other organs. Researchers will collect blood samples from up to 84 participants and their parents to look for changes in the PORCN gene or other unknown…
Sponsor: Baylor College of Medicine • Aim: Knowledge-focused
Last updated May 22, 2026 13:54 UTC
-
Brain-Controlled device could revolutionize OCD treatment
Knowledge-focused OngoingThis study is for people with severe, hard-to-treat obsessive-compulsive disorder (OCD). Researchers are testing a new type of deep brain stimulation that uses the brain's own signals to automatically adjust the electrical pulses. The goal is to improve symptom control and reduce…
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Knowledge-focused
Last updated May 20, 2026 11:58 UTC
-
Protein power: NICU diet may shape preemies' future growth
Knowledge-focused TerminatedThis study follows up on premature babies (born weighing 2.2 pounds or less) who received either a standard or high-protein diet while in the NICU. Researchers want to see if the higher protein diet leads to better growth, body composition, and brain development at 18-24 months o…
Sponsor: Baylor College of Medicine • Aim: Knowledge-focused
Last updated May 20, 2026 11:57 UTC